The Efficacy of Fimasartan for Cardiovascular Events and Metabolic Syndrome (K-MetS Study): Rationale, Design and Participant Characteristics

Fimasartan, the eighth angiotensin receptor blocker, was launched in March 2011 and was found to have an excellent efficacy and safety profile in a large cross-sectional population study [Safety and Efficacy of Fimasartan in Patients with Arterial Hypertension (Safe-KanArb); Park et al.: Am J Cardio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pulse
Main Authors: Kim, Changsoo, Kim, Min Young, Kang, Dae Ryong, Kim, Jang-Young, Park, Jeong Bae
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2014
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4315348/
https://ncbi.nlm.nih.gov/pubmed/26587436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000360965
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados